In previous studies, we demonstrated that CLDN6 mitigated the malignant phenotype of MCF-7 breast cancer cells, and the expression of CLDN6 was undetectable or at low levels in human breast cancer cells [4]. The gene discussed is CLDN6; the disease is breast cancer.